Hand holding holographic display of various icons relating to data security

The Growing Importance of Cybersecurity in Medical Devices

In an era where medical devices are increasingly connected to networks, hospitals, and even personal mobile devices, cybersecurity has become a critical pillar of patient safety and regulatory compliance. From insulin pumps to AI-powered imaging systems, the risk of cyber threats affecting medical devices has surged, as demonstrated by the rise in cyberattacks on healthcare networks and medical devices, including the 2020 attack on the Universal Healthcare Device Systems, which compromised several devices across hospitals1.

In the medical device industry, protecting sensitive data and managing security risks are paramount. A widely accepted global standard, ISO/IEC 27001, provides a structured framework for achieving these goals. This framework is especially relevant for medical devices that connect to hospital networks, cloud systems, or personal devices, where cyber threats can jeopardize patient safety. By adopting ISO 27001, manufacturers can not only enhance their security protections but also ensure compliance across various international markets.

In the U.S., however, regulatory guidance is also evolving to address the growing cybersecurity concerns specific to medical devices. In September 2023, the FDA issued its guidance, “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions,” which clarifies the agency’s expectations regarding cybersecurity throughout the lifecycle of medical devices. This document underscores the importance of security risk management, threat modeling, and vulnerability handling, further cementing the need for manufacturers to prioritize cybersecurity alongside their product development and compliance strategies.

As the regulatory landscape evolves, medical device companies must adopt a holistic cybersecurity strategy, not just to gain market approval, but to ensure patient safety and protect healthcare infrastructure from emerging threats.

Key FDA Requirements for Cybersecurity in Medical Devices

The FDA’s “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions” guidance outlines important expectations for manufacturers aiming to meet cybersecurity standards. Here are the key takeaways from the FDA’s cybersecurity requirements:

Cybersecurity Management Plan

FDA recommends manufacturers to submit a Cybersecurity Management Plan as part of premarket submission outlining security integration across the device lifecycle, including design, risk management, testing, maintenance, monitoring, and updates for emerging threats.

Security Risk Management Plan

The FDA recommends manufacturers to have a comprehensive Security Risk Management Plan that identifies, assesses, and mitigates cybersecurity risks throughout the device’s lifecycle. Manufacturers must demonstrate thorough risk evaluation and proactive strategies to prevent or address vulnerabilities, given the continuously evolving threat landscape.

Cybersecurity Threat Modeling

The FDA encourages manufacturers to use threat modeling during design to identify potential attack vectors early so that systems are built with appropriate safeguards, including risks related to connectivity, data storage, and communication.

Software Bill of Materials (SBOM)

With the increasing use of third-party and open-source software, the FDA mandates the submission of a Software Bill of Materials (SBOM). This document lists all the software components used in the device, including their versions and any known vulnerabilities. The SBOM is a tool that helps the FDA, manufacturers, and third parties track and manage risks associated with these components.

Cybersecurity Testing

The FDA recommends manufacturers to conduct comprehensive cybersecurity testing, including vulnerability assessments and penetration testing.

Vulnerability Management and Patch Procedures

The FDA expects manufacturers to have a vulnerability management plan for handling cybersecurity risks post-market, including procedures for issuing timely patches and updates to minimize risks to patients and healthcare providers.

Clear Security Labeling

The FDA recommends clear and comprehensive security labeling to inform users of cybersecurity risks and provide guidance on securing the device and managing updates, ensuring awareness of its security features.

Post-market Cybersecurity Monitoring

The FDA recommends postmarket cybersecurity monitoring to ensure devices continue meeting security standards, with systems in place to detect, assess, and address emerging risks.

Why Choose Innovenn for your Medical Device Cybersecurity Planning?

At Innovenn, we understand that cybersecurity is not just a regulatory checkbox. It’s a crucial aspect of patient safety and device reliability and should be woven into your software development from the start of the project. With increasing cybersecurity expectations from the FDA, PATCH Act, and global regulations, medical device manufacturers need a trusted partner to navigate compliance with these regulations and plan for the right safeguards to protect their devices from emerging threats. To learn more and speak to our Subject Matter Experts, please contact us.